Eledon Pharmaceuticals (ELDN) Depreciation and Depletion (2013 - 2017)
Eledon Pharmaceuticals (ELDN) posted Depreciation and Depletion of $17000.0 for Q1 2017, little changed on a QoQ basis from $17000.0 in Q4 2016, and down 67.92% year-over-year from $53000.0 in Q1 2016.
Eledon Pharmaceuticals (ELDN) Depreciation and Depletion (2013 - 2017) Analysis & Trends
Eledon Pharmaceuticals' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $17000.0 for Q1 2017.
- Quarterly Depreciation and Depletion fell 67.92% year-over-year to $17000.0 in Q1 2017, while the trailing twelve-month figure through Mar 2017 was $135000.0 (down 14.01% YoY) and the FY2016 annual result came in at $171000.0, up 56.88% from the prior year.
- Depreciation and Depletion was $17000.0 for Q1 2017 at Eledon Pharmaceuticals, roughly flat from $17000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $56000.0 in Q4 2015 and bottomed at $3000.0 in Q4 2013.
- A 5-year average of $22928.6 and a median of $16500.0 in 2015 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2015 — Depreciation and Depletion soared 1020.0% — and 2016, when it plunged 69.64%.
- Eledon Pharmaceuticals' Depreciation and Depletion stood at $3000.0 in 2013, then surged by 66.67% to $5000.0 in 2014, then surged by 1020.0% to $56000.0 in 2015, then plunged by 69.64% to $17000.0 in 2016, then changed by 0.0% to $17000.0 in 2017.
- Business Quant data shows ELDN's Depreciation and Depletion at $17000.0 in Q1 2017, $17000.0 in Q4 2016, and $49000.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Eledon Pharmaceuticals | 406.41 Mn | 406.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 17,000.00 |
| Mar 31, 2017 | 17,000.00 |
| Dec 31, 2016 | 17,000.00 |
| Dec 31, 2016 | 17,000.00 |
| Sep 30, 2016 | 49,000.00 |
| Sep 30, 2016 | 49,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Dec 31, 2015 | 56,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Sep 30, 2015 | 32,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Mar 31, 2015 | 5,000.00 |
| Mar 31, 2015 | 5,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Dec 31, 2014 | 5,000.00 |